Frequently Asked Questions What would justify switching from semaglutide to tirzepatide
Award-winning scientist Professor Jens Juul Holst, alongside co-authors Professor Sten Madsbad, Professor Jens Meldgaard Bruun, and Novo Nordisk Foundation CEO Mads Krogsgaard Thomsen, trace the scientific breakthroughs and clinical advances that have made GLP-1 therapies, such as Ozempic and Wegovy, essential tools for improving blood sugar control and promoting meaningful, lasting weight loss in patients worldwide
RCTs have previously been successful in influencing management and public health policy, with examples in the Diabetes Prevention Programme [21], DiRECT [22] and DROPLET [23] trials
you only pay if you are prescribed, and nothing if not, so you can check whether a plan is available to you at no cost
Unlike brand-name pens that come with validated storage instructions backed by extensive stability testing, compounded vials rely on general pharmaceutical guidelines that may not capture tirzepatide-specific degradation patterns